Trial Profile
Prevalence of Pneumococcal Nasopharyngeal Carriage following the vaccination programme in American Indian children and their household contacts
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Aug 2023
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- 20 May 2016 New trial record
- 11 May 2016 Results published in the Pediatric Infectious Disease Journal